A LOW-COST SYSTEM FOR MONITORING PH, DISSOLVED OXYGEN AND ALGAL DENSITY IN CONTINUOUS CULTURE OF MICROALGAE


Carbon footprint of industry-sponsored late-stage clinical trials

Objectives To quantify the carbon footprint from a sample of pharma industry sponsored phase III trials.To develop an approach that can readily be applied to future trials by AstraZeneca and other trial sponsors.Design Life cycle assessment including all the sources of carbon emissions associated with a completed, an ongoing empire bump hair and a

read more